PTC Therapeutics (PTCT) Competitors $66.06 -0.17 (-0.26%) Closing price 04:00 PM EasternExtended Trading$66.07 +0.01 (+0.02%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PTCT vs. SMMT, ASND, VTRS, RDY, ROIV, MRNA, QGEN, BBIO, ELAN, and VRNAShould you be buying PTC Therapeutics stock or one of its competitors? The main competitors of PTC Therapeutics include Summit Therapeutics (SMMT), Ascendis Pharma A/S (ASND), Viatris (VTRS), Dr. Reddy's Laboratories (RDY), Roivant Sciences (ROIV), Moderna (MRNA), Qiagen (QGEN), BridgeBio Pharma (BBIO), Elanco Animal Health (ELAN), and Verona Pharma PLC American Depositary Share (VRNA). These companies are all part of the "pharmaceutical products" industry. PTC Therapeutics vs. Its Competitors Summit Therapeutics Ascendis Pharma A/S Viatris Dr. Reddy's Laboratories Roivant Sciences Moderna Qiagen BridgeBio Pharma Elanco Animal Health Verona Pharma PLC American Depositary Share Summit Therapeutics (NASDAQ:SMMT) and PTC Therapeutics (NASDAQ:PTCT) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations and risk. Do analysts prefer SMMT or PTCT? Summit Therapeutics presently has a consensus price target of $31.29, indicating a potential upside of 36.44%. PTC Therapeutics has a consensus price target of $69.00, indicating a potential upside of 4.45%. Given Summit Therapeutics' higher probable upside, equities research analysts plainly believe Summit Therapeutics is more favorable than PTC Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Summit Therapeutics 5 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.44PTC Therapeutics 1 Sell rating(s) 5 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.53 Which has more risk and volatility, SMMT or PTCT? Summit Therapeutics has a beta of -1.13, suggesting that its share price is 213% less volatile than the S&P 500. Comparatively, PTC Therapeutics has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500. Do institutionals and insiders believe in SMMT or PTCT? 4.6% of Summit Therapeutics shares are held by institutional investors. 84.9% of Summit Therapeutics shares are held by insiders. Comparatively, 5.5% of PTC Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is SMMT or PTCT more profitable? PTC Therapeutics has a net margin of 35.65% compared to Summit Therapeutics' net margin of 0.00%. PTC Therapeutics' return on equity of -106.31% beat Summit Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Summit TherapeuticsN/A -208.64% -181.28% PTC Therapeutics 35.65%-106.31%30.61% Which has preferable earnings and valuation, SMMT or PTCT? Summit Therapeutics has higher earnings, but lower revenue than PTC Therapeutics. Summit Therapeutics is trading at a lower price-to-earnings ratio than PTC Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSummit Therapeutics$700K24,333.64-$221.32M-$1.01-22.70PTC Therapeutics$1.76B2.97-$363.30M$6.979.48 Does the media prefer SMMT or PTCT? In the previous week, PTC Therapeutics had 18 more articles in the media than Summit Therapeutics. MarketBeat recorded 28 mentions for PTC Therapeutics and 10 mentions for Summit Therapeutics. Summit Therapeutics' average media sentiment score of 0.77 beat PTC Therapeutics' score of 0.59 indicating that Summit Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Summit Therapeutics 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PTC Therapeutics 10 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryPTC Therapeutics beats Summit Therapeutics on 9 of the 17 factors compared between the two stocks. Get PTC Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTCT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PTCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PTCT vs. The Competition Export to ExcelMetricPTC TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.25B$3.34B$6.05B$10.45BDividend YieldN/A2.31%5.73%4.79%P/E Ratio9.4822.2085.2827.12Price / Sales2.97434.56587.61188.70Price / CashN/A44.9825.7330.17Price / Book-4.6410.3512.656.69Net Income-$363.30M-$52.31M$3.31B$276.03M7 Day Performance1.94%0.57%-0.38%-1.13%1 Month Performance8.14%13.88%8.77%6.48%1 Year Performance69.38%28.83%76.80%34.34% PTC Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PTCTPTC Therapeutics3.2006 of 5 stars$66.06-0.3%$69.00+4.5%+69.8%$5.25B$1.76B9.481,410Analyst RevisionSMMTSummit Therapeutics2.7888 of 5 stars$22.15+3.4%$31.29+41.2%+7.0%$16.45BN/A-21.93110ASNDAscendis Pharma A/S2.9948 of 5 stars$210.83+3.3%$244.36+15.9%+62.6%$12.57B$490.75M-40.861,017Analyst ForecastVTRSViatris1.8438 of 5 stars$10.13-0.6%$10.40+2.7%-14.4%$11.81B$14.74B-3.4932,000Positive NewsRDYDr. Reddy's Laboratories2.5305 of 5 stars$14.12-0.3%$16.95+20.0%-8.4%$11.79B$334.26B21.3927,811ROIVRoivant Sciences3.3936 of 5 stars$16.26+0.6%$19.94+22.6%+34.8%$11.10B$23.23M-23.23860MRNAModerna4.2459 of 5 stars$27.54-3.3%$41.81+51.8%-54.0%$10.72B$3.24B-3.665,800Analyst ForecastQGENQiagen4.3614 of 5 stars$46.99+0.4%$49.40+5.1%+9.9%$10.45B$1.98B27.765,765Positive NewsAnalyst DowngradeBBIOBridgeBio Pharma4.1492 of 5 stars$54.61+3.3%$63.94+17.1%+114.2%$10.44B$221.90M-13.35400Insider TradeELANElanco Animal Health2.5952 of 5 stars$20.68+0.2%$18.33-11.3%+37.6%$10.27B$4.44B24.059,000VRNAVerona Pharma PLC American Depositary Share1.5397 of 5 stars$106.91+0.1%$109.00+2.0%N/A$9.21B$42.28M-107.9930Positive News Related Companies and Tools Related Companies SMMT Alternatives ASND Alternatives VTRS Alternatives RDY Alternatives ROIV Alternatives MRNA Alternatives QGEN Alternatives BBIO Alternatives ELAN Alternatives VRNA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PTCT) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PTC Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PTC Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
